1-20 of 73
Nikolai A. Podoltsev
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

State‐Level Acute Myeloid Leukemia Incidence and Mortality Trends and Association with Obesity in the United States

Lixin Kang, Xiaomei Ma, Nikolai A. Podoltsev, Jessica M. Stempel, Rong Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5184.
https://doi.org/10.1182/blood-2023-186428
Published: 2023
Journal Articles

A Global, Phase 3, Randomized, Double-Blind Study to Evaluate Safety and Efficacy of Selinexor, an XPO-1 Inhibitor, in Combination with Ruxolitinib in JAK Inhibitor-Naïve Myelofibrosis (XPORT-MF-034)

Keri Maher, Raajit K. Rampal, Prithviraj Bose, Nikolai A. Podoltsev, Claire N Harrison, Junshik Hong, Xulong Wang, Kamal Chamoun, John Mascarenhas
Journal: Blood
Blood (2023) 142 (Supplement 1): 3209.
https://doi.org/10.1182/blood-2023-180695
Published: 2023
Journal Articles

Trial in Progress: Venetoclax in Combination with ASTX727, an All-Oral Therapy for Chronic Myelomonocytic Leukemia and Other MDS/MPN with Excess Blasts (VICTORY MDS/MPN): A Randomized, Phase 2 Trial

Rory M. Shallis, Ondrej Blaha, Stephanie Halene, Lourdes Mendez, Nikolai A. Podoltsev, Anne Caldwell, Jan Philipp Bewersdorf, Richard F. Little, Richard Piekarz, Mrinal M. Patnaik, Steven D. Gore, Amer M. Zeidan
Journal: Blood
Blood (2023) 142 (Supplement 1): 3252.
https://doi.org/10.1182/blood-2023-182814
Published: 2023
Journal Articles

Evaluating Inpatient Care Team Models in Hematology and Oncology Fellowship Programs in the United States

Jessica M. Stempel, Allison J. Li, Alexander B Pine, Valentina Restrepo, Jan Philipp Bewersdorf, Maximilian Stahl, Nikolai A. Podoltsev, Lourdes Mendez, Rory M. Shallis, Deepa Rangachari, Alfred I Lee, Laura C. Michaelis, Amer M. Zeidan
Journal: Blood
Blood (2023) 142 (Supplement 1): 2319.
https://doi.org/10.1182/blood-2023-187163
Published: 2023
Journal Articles

Clinical Factors but Not Somatic Mutations Predict for Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplant: Analysis of the North American Myelofibrosis Transplant Outcome (NAMTO) Study

Helen Ajufo, Andriy Derkach, Raajit K. Rampal, Christopher Famulare, David Nemirovsky, Jordan Chervin, Vincent Ho, Vikas Gupta, Auro Viswabandya, H. Joachim Deeg, Tim Monahan, Tania Jain, Richard J. Jones, Jeanne Palmer, Aaron T. Gerds, Alla Keyzner, Jonathan Lagdameo, Alexandra Gomez-Arteaga, Koen Van Besien, Nikolai A. Podoltsev, Christian Puzo, Satyajit Kosuri, Idoroenyi Amanam, Roni Tamari
Journal: Blood
Blood (2023) 142 (Supplement 1): 3181.
https://doi.org/10.1182/blood-2023-173441
Published: 2023
Journal Articles

Feasibility, Safety and Predictors of Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia Discharged “Early” after Intensive Induction Therapy

Cameron Hunter, Wei Cheng, Stephanie Halene, Lourdes Mendez, Nikolai A. Podoltsev, Amer M. Zeidan, Lisa Barbarotta, Rory M. Shallis
Journal: Blood
Blood (2023) 142 (Supplement 1): 589.
https://doi.org/10.1182/blood-2023-182989
Published: 2023
Journal Articles

The Value and Success of Live Plus Online Enduring CME/CE on Hematology/Oncology Specialists' Ability to Care for Patients with Hematologic Disorders

Michelle A. Worst, Heather P. Friedman, Sarah E. Bomba, Megan Whitney, Deborah Middleton, Emily Mikhael, Haleh Kadkhoda, Cong Zhang, Nikolai A. Podoltsev
Journal: Blood
Blood (2023) 142 (Supplement 1): 7282.
https://doi.org/10.1182/blood-2023-180360
Published: 2023
Journal Articles

Feasibility and Safety of Outpatient Hypomethylating Agent (HMA) + Venetoclax (Ven) Initiation +/- Ramp-up for Patients (pts) with Newly-Diagnosed Acute Myeloid Leukemia (AML)

Rory Michael Shallis, Julian Weiss, Eric S. Winer, Talha Badar, Alok Swaroop, Peter Doukas, Emily Geramita, Henry Le, Sonal Agarwal, Man Yee Merl, Annie Im, Yasmin Abaza, Mark R. Litzow, Nikolai A. Podoltsev
Journal: Blood
Blood (2022) 140 (Supplement 1): 8921–8922.
https://doi.org/10.1182/blood-2022-165446
Published: 2022
Journal Articles

A Multi-Center Phase Ib Trial of the Histone Deactylase Inhibitor (HDACi) Entinostat in Combination with Anti-PD1 Antibody Pembrolizumab in Patients with Refractory/Relapsed Myelodysplastic Syndromes (RR-MDS) or Oligoblastic Acute Myeloid Leukemia (RR-AML) after Hypomethylating Agent (HMA) Failure

Jan Philipp Bewersdorf, Rory Michael Shallis, Elad Sharon, Anne Caldwell, Wei Wei, Abdulraheem Yacoub, Yazan F. Madanat, Joshua F. Zeidner, Jessica K. Altman, Olatoyosi Odenike, Swaroopa Yerrabothala, Tibor Kovacsovics, Nikolai A. Podoltsev, Stephanie Halene, Richard F. Little, Richard Piekarz, Steven D. Gore, Tae Kon Kim, Amer M. Zeidan
Journal: Blood
Blood (2022) 140 (Supplement 1): 9084–9086.
https://doi.org/10.1182/blood-2022-158626
Published: 2022
Journal Articles

Improving Diversity, Equity, and Inclusion Education in Hematology/Oncology Training

Anna Kress, Benjamin Lu, Ayesha Butt, Jana Christian, Nikolai A. Podoltsev, Michael Hurwitz, Sarah Goldberg, Barbara Burtness, Iris Isufi, Darin Latimore, Alfred I. Lee, Pamela Kunz
Journal: Blood
Blood (2022) 140 (Supplement 1): 5029–5030.
https://doi.org/10.1182/blood-2022-170950
Published: 2022
Journal Articles

Cost-Effectiveness of Azacitidine and Ivosidenib in Newly Diagnosed Older, Intensive Chemotherapy-Ineligible Patients with IDH1 -Mutant Acute Myeloid Leukemia

Jan Philipp Bewersdorf, Kishan K Patel, George Goshua, Rory Michael Shallis, Nikolai A. Podoltsev, Maximilian F. Stahl, Jessica M. Stempel, Eytan Stein, Scott F. Huntington, Amer M. Zeidan
Journal: Blood
Blood (2022) 140 (Supplement 1): 319–321.
https://doi.org/10.1182/blood-2022-158465
Published: 2022
Journal Articles

Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based Analysis

Mengyang Di, Jessica B Long, Shalin K. Kothari, Tarsheen Sethi, Amer M. Zeidan, Nikolai A. Podoltsev, Rory Michael Shallis, Rong Wang, Jessica M. Stempel, Xiaomei Ma, Scott F. Huntington
Journal: Blood
Blood (2022) 140 (Supplement 1): 10904–10906.
https://doi.org/10.1182/blood-2022-164959
Published: 2022
Journal Articles

Exploratory Predictors for Hydroxyurea Treatment Duration in Polycythemia Vera: A Retrospective Multi-Institutional Database Analysis

Chen Zhang, Douglas Tremblay, John Magnotti, Lukas Ronner, Nikolai A. Podoltsev, Jason Gotlib, Mark L. Heaney, Andrew Kuykendall, Casey L. O'Connell, Angela G Fleischman, Ruben Mesa, Abdulraheem Yacoub, John Mascarenhas, Jamile M. Shammo
Journal: Blood
Blood (2022) 140 (Supplement 1): 9693–9695.
https://doi.org/10.1182/blood-2022-157873
Published: 2022
Journal Articles

Second Malignancies Among Older Patients with Classical Myeloproliferative Neoplasms Treated with Ruxolitinib

Jessica M. Stempel, Rong Wang, Rory Michael Shallis, Scott F. Huntington, Amer M. Zeidan, Natalia Neparidze, Mengyang Di, Xiaomei Ma, Nikolai A. Podoltsev
Journal: Blood
Blood (2022) 140 (Supplement 1): 11004–11006.
https://doi.org/10.1182/blood-2022-165156
Published: 2022
Journal Articles

Follow-up of patients with R/R FLT3- mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

Clinical Trials & Observations
Alexander E. Perl, Richard A. Larson, Nikolai A. Podoltsev, Stephen Strickland, Eunice S. Wang, Ehab Atallah, Gary J. Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Récher, Sung-Soo Yoon, Naoko Hosono, Masahiro Onozawa, Shigeru Chiba, Hee-Je Kim, Nahla Hasabou, Qiaoyang Lu, Ramon Tiu, Mark J. Levis
Journal: Blood
Blood (2022) 139 (23): 3366–3375.
https://doi.org/10.1182/blood.2021011583
Published: 2022
Includes: Supplemental data
Journal Articles

Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia

Jan Philipp Bewersdorf, Kishan K. Patel, George Goshua, Rory M. Shallis, Nikolai A. Podoltsev, Scott F. Huntington, Amer M. Zeidan
Journal: Blood
Blood (2022) 139 (11): 1766–1770.
https://doi.org/10.1182/blood.2021014401
Published: 2022
Includes: Supplemental data
Journal Articles

Oncologist Sub-Specialization, Care Setting, and Multiple Myeloma Treatment and Outcomes

Amy J. Davidoff, PhD, Jessica B Long, MPH, Natalia Neparidze, MD, Jan Philipp Bewersdorf, MD, Rory M. Shallis, MD, Nikolai A. Podoltsev, MD PhD, Rong Wang, PhD, Steven D. Gore, MD, Amer M. Zeidan, MBBS, MHS, Scott F. Huntington, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-140728
Published: 2020
Journal Articles

Clinical Outcomes in Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated with Gilteritinib Who Received Prior Midostaurin or Sorafenib

Alexander E. Perl, MD, Jessica K. Altman, MD, Naoko Hosono, MD PhD, Pau Montesinos, MD PhD, Nikolai A. Podoltsev, MD PhD, Giovanni Martinelli, MD, Catherine C. Smith, MD, Mark Levis, MD PhD, Christoph Röllig, Prof., MD, Marco Groß-Langenhoff, PhD, Nahla Hasabou, MD, Qiaoyang Lu, MS, Ramon V. Tiu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-136395
Published: 2020
Journal Articles

Trial in Progress: Glad-AML - a Randomized, Phase 2 Trial of Glasdegib with Two Standard Decitabine Regimens for Older Patients with Newly-Diagnosed, Poor-Risk Acute Myeloid Leukemia

Rory M. Shallis, MD, Nikolai A. Podoltsev, MD PhD, Thomas Prebet, MD PhD, Amer M. Zeidan, MBBS, MHS
Journal: Blood
Blood (2020) 136 (Supplement 1): 29.
https://doi.org/10.1182/blood-2020-139428
Published: 2020
Journal Articles

Predictors of Tyrosine Kinase Inhibitor Use Among Older Patients with Chronic Myeloid Leukemia in the United States

Rong Wang, PhD, Rory M. Shallis, MD, Jan Philipp Bewersdorf, MD, Amer M. Zeidan, MBBS, MHS, Scott F. Huntington, MD MPH, Xiaomei Ma, PhD, Nikolai A. Podoltsev, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-139468
Published: 2020